oxytetracycline

oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with oxytetracycline?

oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with oxytetracycline

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abortion, Veterinary D000034 5 associated lipids
Abscess D000038 13 associated lipids
Acne Vulgaris D000152 35 associated lipids
Acrocephalosyndactylia D000168 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Anaplasmataceae Infections D000711 3 associated lipids
Anaplasmosis D000712 3 associated lipids
Anemia D000740 21 associated lipids
Arthritis D001168 41 associated lipids
Per page 10 20 50 100 | Total 137

PubChem Associated disorders and diseases

What pathways are associated with oxytetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with oxytetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with oxytetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with oxytetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with oxytetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with oxytetracycline?

Disease model

Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with oxytetracycline

Download all related citations
Per page 10 20 50 100 | Total 5138
Authors Title Published Journal PubMed Link
Magonigle RA and Newby TJ Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections. 1984 Am. J. Vet. Res. pmid:6731981
Roby TO et al. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline. 1978 Am. J. Vet. Res. pmid:677530
Nicoletti P et al. Efficacy of various treatment regimens, using liposomal streptomycin in cows with brucellosis. 1989 Am. J. Vet. Res. pmid:2505648
Magonigle RA et al. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis. 1978 Am. J. Vet. Res. pmid:697150
Varma KJ and Paul BS Pharmacokinetics and plasma protein binding (in vitro) of oxytetracycline in buffalo (Bubalus bubalis). 1983 Am. J. Vet. Res. pmid:6838044
Wooley RE et al. Attempted reversal of oxytetracycline resistance of Proteus mirabilis by EDTA-tromethamine lavage in experimentally induced canine and feline cystitis. 1975 Am. J. Vet. Res. pmid:811139
Wooley RE et al. In vitro action of combinations of antimicrobial agents and EDTA-tromethamine on Pseudomonas aeruginosa. 1983 Am. J. Vet. Res. pmid:6414345
Kaneene JB et al. Drug residues in milk after intrauterine injection of oxytetracycline, lincomycin-spectinomycin, and povidone-iodine in cows with metritis. 1986 Am. J. Vet. Res. pmid:2942064
MacNeil JD et al. Bioassay techniques and high-performance liquid chromatography for detection of oxytetracycline residues in tissues from calves. 1989 Am. J. Vet. Res. pmid:2919831
Arnoczky SP et al. In vitro effects of oxytetracycline on matrix metalloproteinase-1 mRNA expression and on collagen gel contraction by cultured myofibroblasts obtained from the accessory ligament of foals. 2004 Am. J. Vet. Res. pmid:15077693
Palmer JE et al. Effect of treatment with oxytetracycline during the acute stages of experimentally induced equine ehrlichial colitis in ponies. 1992 Am. J. Vet. Res. pmid:1476312
Oukessou M et al. Pharmacokinetics and local tolerance of a long-acting oxytetracycline formulation in camels. 1992 Am. J. Vet. Res. pmid:1416372
byford RL et al. Chemoprophylaxis of vector-borne anaplasmosis with sustained-release boluses. 1981 Am. J. Vet. Res. pmid:7340579
Hidalgo RJ Propagation of Anaplasma marginale in bovine lymph node cell culture. 1975 Am. J. Vet. Res. pmid:1094867
Fugler LA et al. Plasma matrix metalloproteinase activity in horses after intravenous infusion of lipopolysaccharide and treatment with matrix metalloproteinase inhibitors. 2013 Am. J. Vet. Res. pmid:23438126
Edmondson AJ et al. Survival analysis for evaluation of corneal ulcer healing times in calves with naturally acquired infectious bovine keratoconjunctivitis. 1989 Am. J. Vet. Res. pmid:2764337
Ames TR and Patterson EB Oxytetracycline concentrations in plasma and lung of healthy and pneumonic calves, using two oxytetracycline preparations. 1985 Am. J. Vet. Res. pmid:3909863
Button C and Mülders MS Effects of oxytetracycline in propylene glycol, oxytetracycline in saline solution, and propylene glycol alone on blood ionized calcium and plasma total calcium in sheep. 1984 Am. J. Vet. Res. pmid:6476580
Paulsen DB et al. Use of an indwelling bronchial catheter model of bovine pneumonic pasteurellosis for evaluation of therapeutic efficacy of various compounds. 1992 Am. J. Vet. Res. pmid:1524292
Tornquist SJ et al. Use of a polymerase chain reaction assay to study response to oxytetracycline treatment in experimental Candidatus Mycoplasma haemolamae infection in alpacas. 2009 Am. J. Vet. Res. pmid:19719425